Tecentriq in combination with Avastin in 1L HCC approved in Japan

Dear Investor, Please find attached a press release by Chugai:https://www.roche.com/200925_IR_eTecentriq_Avastin_HCC_approval.pdf Do not hesitate to contact us for any further questions. With best regards,
Source: Roche Investor Update - Category: Pharmaceuticals Source Type: news